By Tom Crosby, RESI Conference Manager, LSN
Angels represent an extremely important pool of capital for a fundraising entrepreneur, especially now that they have begun syndicating and participating in larger financing rounds. To help RESI attendees better understand how to receive an allocation from an angel, LSN has assembled a world-class panel of accredited investors to sit on the September 17 Angel Group session.
Moderated by Barbara Nelsen, an active solo angel and member of Sofia Angel Fund (which invests in companies operated by or for women), the audience will hear from:
- Bill Whitaker, Managing Director, Golden Seeds
- Stephen Nagler, Executive Director, MedPro Investors LLC
- Stephen Goodman, Co-Founder, Mid-Atlantic Bio Angels
- Praveen Tailam, Managing Director, TiE Angels
This session will help scientist entrepreneurs understand the perspective of the angel. Angels will explain their investment preferences, and those of their respective syndicates (when angels band together). What sectors are most attractive to angels? How does an angel group filter, evaluate and parse the plethora of deals that surface?
Other topics of discussion will include their criteria for management team, stage of technology, and whether there is a preference for regional or global firms. What is the difference in presenting to an angel group versus a traditional one-on-one investor meeting — and how does the vetting process work? If you’re looking for angel capital to move your technology forward, don’t miss this session of expert insight at RESI.
Next Phase Newsletter 
Leave a comment